Therefore, assessing MKX/MKXAS1 expression, MMR status, and MSI can be crucial in determining prognosis and guiding treatment decisions for gastric, pancreatic, and esophageal cancers [69,70]. This evidence concerns the gene MKX and esophageal cancer.